Legend Biotech Corp ADR (LEGN)
32.61 x 1 32.90 x 5
Post-market by (Cboe BZX)
32.80 -0.66 (-1.97%) 04/17/25 [NASDAQ]
32.61 x 1 32.90 x 5
Post-market 32.80 unch (unch) 16:07 ET
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select Fields| Symbol | LEGN | JAZZ | TGTX | ||
| Company | Legend Biotech Corp ADR | Jazz Pharma Plc | Tg Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 33.28 | 101.37 | 37.90 | ||
| High | 33.29 | 104.53 | 38.92 | ||
| Low | 31.68 | 100.54 | 37.59 | ||
| Last | 32.80 | 102.78 | 38.32 | ||
| Change | -0.66 | +1.23 | +0.11 | ||
| % Change | -1.97% | +1.21% | +0.29% | ||
| Volume | 1,812,700 | 995,200 | 1,075,700 | ||
| 20-Day Average Volume | 1,602,845 | 1,619,080 | 2,934,400 | ||
| Previous Close | 33.46 | 101.55 | 38.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.28 | 116.70 | 38.91 | ||
| 20-Day Raw Stochastic | 43.58% | 15.46% | 59.42% | ||
| 20-Day Relative Strength | 45.61% | 33.71% | 53.21% | ||
| Weighted Alpha | -33.14 | -13.93 | +140.49 | ||
| Today's Opinion | 100% Sell | 40% Sell | 80% Buy | ||
| Previous Opinion | 100% Sell | 24% Sell | 80% Buy | ||
| Last Month's Opinion | 32% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.86% since 04/10/25 | +0.72% since 04/10/25 | +6.50% since 04/10/25 | ||
| Low | 31.23 on 04/11/25 | 98.59 on 04/11/25 | 35.29 on 04/11/25 | ||
| High | 35.11 on 04/15/25 | 104.53 on 04/17/25 | 39.18 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | -13.55% since 03/17/25 | -26.70% since 03/17/25 | -6.67% since 03/17/25 | ||
| Low | 29.27 on 04/09/25 | 95.49 on 04/09/25 | 31.00 on 04/09/25 | ||
| High | 38.25 on 03/18/25 | 142.64 on 03/24/25 | 43.32 on 03/24/25 | ||
| 3-Month | |||||
| %Chg | +0.43% since 01/17/25 | -15.18% since 01/17/25 | +29.68% since 01/17/25 | ||
| Low | 29.27 on 04/09/25 | 95.49 on 04/09/25 | 28.17 on 02/28/25 | ||
| High | 40.00 on 02/21/25 | 148.06 on 02/26/25 | 43.32 on 03/24/25 | ||
| 6-Month | |||||
| %Chg | -23.88% since 10/17/24 | -10.34% since 10/17/24 | +60.07% since 10/17/24 | ||
| Low | 29.27 on 04/09/25 | 95.49 on 04/09/25 | 22.61 on 10/24/24 | ||
| High | 47.79 on 11/05/24 | 148.06 on 02/26/25 | 43.32 on 03/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,023,687 | 6,242,034 | 6,018,960 | ||
| Shares Outstanding, K | 183,649 | 60,732 | 157,071 | ||
| Annual Sales | 627,240,000 | 4,068,950,000 | 329,000,000 | ||
| Annual Net Income | -177,030,000 | 560,120,000 | 23,380,000 | ||
| Last Quarter Sales | 186,520,000 | 1,088,170,000 | 108,190,000 | ||
| Last Quarter Net Income | 26,280,000 | 191,120,000 | 23,330,000 | ||
| 60-Month Beta | 0.21 | 0.42 | 2.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 03/11/25 | 6.60 on 02/25/25 | 0.15 on 03/03/25 | ||
| Latest Earnings Date | 05/12/25 | 05/07/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 5.58 | 272.93 | ||